Medtronic plc (MDT) Financial Statements
Industry: Electromedical & Electrotherapeutic Apparatus
In fiscal 2026, Medtronic reported revenue of $36.36B, up 8.4% from $33.54B the year before. Net income was $4.80B (a 13.2% net margin), or $3.73 per diluted share. Gross margin was 65.0% and operating margin was 17.8%. Operating activities generated $7.33B of cash, leaving $5.43B of free cash flow. At fiscal year end, Medtronic held $93.03B in total assets against $42.96B in total liabilities, including $1.95B of cash and equivalents.
Open the full interactive Medtronic financials → Quarterly statements, key ratios, valuation history and price charts.
Medtronic Key Stats
| Share Price | $93.01 |
|---|---|
| Market Cap | $119.53B |
| P/E Ratio | 24.9 |
| Revenue YoY Growth | +8.4% |
| 52-Week Range | $72.50 – $101.97 |
| Shares Outstanding | 1.28 billion (basic, 2027 Q1) |
Medtronic Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $30.12B | $31.69B | $31.23B | $32.36B | $33.54B | $36.36B |
| Cost of Goods Sold | $10.48B | $10.14B | $10.72B | $11.22B | $11.63B | $12.72B |
| Gross Profit | $19.63B | $21.54B | $20.51B | $21.15B | $21.91B | $23.64B |
| Operating Income | $4.48B | $5.75B | $5.49B | $5.14B | $5.96B | $6.47B |
| Pre-Tax Income | $3.90B | $5.52B | $5.36B | $4.84B | $5.63B | $6.14B |
| Income Tax | $265.0M | $456.0M | $1.58B | $1.13B | $936.0M | $1.30B |
| Net Income | $3.61B | $5.04B | $3.76B | $3.68B | $4.66B | $4.80B |
| Diluted EPS | $2.66 | $3.73 | $2.82 | $2.76 | $3.61 | $3.73 |
Medtronic Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $8.96B | $9.02B | $9.81B | $9.76B |
| Net Income | $1.37B | $1.14B | $1.24B | $1.47B |
| Diluted EPS | $1.07 | $0.89 | $0.97 | $1.14 |
Medtronic Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.59B | $3.71B | $1.54B | $1.28B | $2.22B | $1.95B |
| Current Assets | $22.55B | $23.06B | $21.68B | $21.93B | $23.81B | $24.79B |
| Total Assets | $93.08B | $90.98B | $90.95B | $89.98B | $91.68B | $93.03B |
| Current Liabilities | $8.51B | $12.39B | $9.05B | $10.79B | $12.88B | $11.66B |
| Total Long-Term Debt | $26.38B | $20.37B | $24.34B | $23.93B | $25.64B | $26.17B |
| Total Liabilities | $41.48B | $38.26B | $39.28B | $39.56B | $43.42B | $42.96B |
| Shareholders' Equity | $51.43B | $52.55B | $51.48B | $50.21B | $48.02B | $49.46B |
Medtronic Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $6.24B | $7.35B | $6.04B | $6.79B | $7.04B | $7.33B |
| Cash From Investing | -$2.87B | -$1.66B | -$3.49B | -$2.37B | -$1.94B | -$2.93B |
| Cash From Financing | -$4.14B | -$5.34B | -$4.96B | -$4.45B | -$4.36B | -$4.75B |
| Free Cash Flow | $4.88B | $5.98B | $4.58B | $5.20B | $5.18B | $5.43B |
Figures from Medtronic's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Medtronic financials page for every line item.
Medtronic Company Profile
| Ticker | MDT |
|---|---|
| Exchange | NYSE |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Headquarters | Galway |
| Fiscal Year End | April 24 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001613103 |
Frequently Asked Questions
What was Medtronic's revenue in fiscal 2026?
Medtronic (MDT) reported revenue of $36.36B for fiscal 2026.
What is Medtronic's annual revenue history?
Medtronic's annual revenue by fiscal year: 2021: $30.12B; 2022: $31.69B; 2023: $31.23B; 2024: $32.36B; 2025: $33.54B; 2026: $36.36B.
What was Medtronic's net income in fiscal 2026?
Medtronic reported net income of $4.80B for fiscal 2026.
What was Medtronic's earnings per share (EPS) in fiscal 2026?
Medtronic's diluted EPS was $3.73 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Medtronic generate in fiscal 2026?
Medtronic generated $5.43B of free cash flow in fiscal 2026.
What was Medtronic's revenue last quarter?
In its most recent reported quarter (2027 Q1), Medtronic reported revenue of $9.76B.
How much debt does Medtronic have?
Medtronic reported $26.17B of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Medtronic are outstanding?
Medtronic reported a weighted average of 1.28 billion basic shares outstanding in 2027 Q1.
What is Medtronic's market cap?
Based on its latest closing price, Medtronic (MDT) has a market capitalization of about $119.53B.
When does Medtronic's fiscal year end?
Medtronic's fiscal year end, as registered with the SEC, is April 24.
Where is Medtronic headquartered?
Medtronic lists its business address in Galway in its SEC filings.